Publisher： Bentham Science Publishers
E-ISSN： 1875-614x|6|3|205-210
ISSN： 1871-5230
Source： Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol.6, Iss.3, 2007-08, pp. : 205-210
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Talamonti Marina Spallone Giulia Di Stefani Alessandro Costanzo Antonio Chimenti Sergio
Expert Opinion on Drug Safety, Vol. 10, Iss. 2, 2011-03 ,pp. :
Access to resources
Recommend
Expert Opinion on Investigational Drugs, Vol. 13, Iss. 5, 2004-05 ,pp. :
Efalizumab: Erythroderma: case report
Reactions Weekly, Vol. 1, Iss. 1245, 2009-01 ,pp. :
Efalizumab: Candidiasis: case report
Reactions Weekly, Vol. 1, Iss. 1226, 2008-01 ,pp. :
Efalizumab: Pancytopenia: case report
Reactions Weekly, Vol. 1, Iss. 1211, 2008-01 ,pp. :